GGrantIndex
Sort

78,016 grants matching breast cancer

Biology of Mammary Gland Development and Tumorigenesis

$984,317
Gilbert Smith · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

CHEMOTACTIC SIGNALS REGULATING HUMAN NEUTROPHIL AND BREAST METASTATIC MIGRATION

$984,212
Carole Parent · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Biomolecular Recognition and Binding Mechanisms

$984,067
Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

NCI, National Clinical Trials Network Lead Academic Participating Site (LAPS) UG1

$984,029
Steven R Alberts · Mayo Clinic Rochester · UG1 · FY2020 · CA

NCI, National Clinical Trials Network Lead Academic Participating Site (LAPS) UG1

$984,029
Steven R Alberts · Mayo Clinic Rochester · UG1 · FY2019 · CA

Vitamin D, Related Genes and Breast Cancer Risk

$983,933
Anne Zeleniuch-Jacquotte · New York University School Of Medicine · R01 · FY2010 · CA

Structural studies of molecular targets for drug development

$983,703
David S Waugh · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Pregnancy and Prenatal PAHs and other Environmental Exposures and Breast Cancer

$983,672
Mary Beth Terry · Columbia University Health Sciences · U01 · FY2015 · ES

Northwestern Cancer Prevention Consortium

$983,603
Seema Ahsan Khan · Northwestern University At Chicago · UG1 · FY2024 · CA

ABL-REGULATED TRANSCRIPTIONAL AND EPIGENETIC NETWORKS PROMOTE OUTGROWTH OF BREAST CANCER METASTASES REVEALING NOVEL THERAPEUTIC TARGETS

$983,175
Duke University · · FY2022 · Defense Health Agency

Advancing the Quality of Cancer Care through Behavioral Economics and Implementation Science

$983,060
Rinad Sary Beidas · University Of Pennsylvania · P50 · FY2020 · CA

Spectroscopic Localization of Breast Cancer

$982,695
David A. Benaron · Spectros Corporation · R44 · FY2009 · CA

Genetic Epidemiology of Lung Cancer

$982,565
Marshall W Anderson · University Of Cincinnati · U01 · FY2009 · CA

Promoting follow-up of abnormal cancer screening tests using population-basedsystems to support stepped care multilevel intervention

$982,509
Jennifer S Haas · Massachusetts General Hospital · U01 · FY2020 · CA

Pathway Discovery and Target Validation for Outgrowth of Breast Cancer Metastases

$982,500
Joel S. Bader · Johns Hopkins University · U01 · FY2020 · CA

Pathway Discovery and Target Validation for Outgrowth of Breast Cancer Metastases

$982,500
Joel S. Bader · Johns Hopkins University · U01 · FY2021 · CA

THE AUSTRALIAN BREAST CANCER FAMILY REGISTRY

$982,480
University Of Melbourne · U01 · FY2002 · CA

1/2 Mechanisms of alcohol pathology: a collaborative partnership between NCCU and UNC

$982,262
Gregory Jay Cole · North Carolina Central University · U54 · FY2018 · AA

1/2 Mechanisms of alcohol pathology: a collaborative partnership between NCCU and UNC

$982,262
Gregory Jay Cole · North Carolina Central University · U54 · FY2019 · AA

Molecular Imaging and Theranostics of Cancer

$982,256
Zaver M Bhujwalla · Johns Hopkins University · R35 · FY2021 · CA

CLINICAL STUDY OF MRI IN BREAST CANCER

$982,234
University Of Pennsylvania · U01 · FY2000 · CA

Targeting mutant estrogen receptor driven breast cancers

$982,110
Ganesh V Raj · Etirarx, Llc · R44 · FY2021 · CA

A novel glycan-based selectin and complement inhibitor for at-home disease-modifying rescue of pain crisis in sickle cell disease

$982,081
John Paderi John Paderi John Paderi · Ihp Therapeutics, Inc. · UH3 · FY2025 · NS

Stem Cell Biology, Cancer Stem Cell Biology, and Cancer Immunotherapy

$981,896
Irving Lerner Weissman · Stanford University · R35 · FY2019 · CA

Molecular Imaging and Theranostics of Cancer

$981,694
Zaver M Bhujwalla · Johns Hopkins University · R35 · FY2020 · CA